Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nemolizumab in the treatment of atopic dermatitis with moderate to severe excoriation

Nemolizumab in the treatment of atopic dermatitis with moderate to severe excoriation

US Patent 12435147 · Granted Oct 7, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical composition for prevention and/or treatment of atopic dermatitis 2025
Pharmaceutical composition for prevention and/or treatment of atopic dermatitis 2025
Pharmaceutical composition for prevention and/or treatment of atopic dermatitis 2023
Pharmaceutical composition for prevention and/or treatment of atopic dermatitis 2023
Use of ivermectin and brimonidine in the treatment and/or prevention of moderate2022
Pharmaceutical composition for prevention and/or treatment of atopic dermatitis 2020
Pharmaceutical composition for prevention and/or treatment of atopic dermatitis 2020
Maintenance therapy regime/regimen for the treatment of acne2015
Concurrent therapy regime/regimen for the treatment of acne related diseases2014